On May 15, 2019, the 76th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
PRESS RELEASE: Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD CONTACT: Betty Aldworth, Director of Communications and Events, MAPS Media Requests: …
The MDMA Therapy Training Program has launched a series of trainings to prepare therapy providers to become eligible to work on a MAPS MDMA/PTSD protocol. In January 2019, MAPS PBC submitted an MDMA-assisted …
On April 2, 2019, six United States Senators sent Attorney General William Barr a formal letter to follow-up about pending applications to manufacture marijuana for scientific research. “Our nation’s …
On March 28, 2019, United States Senators Brian Schatz and Cory A. Booker of the Senate Judiciary Committee sent a formal letter to Attorney General William Barr regarding the delay of licensing new manufacturers …
On January 15, 2019, the 73rd participant officially enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On December 19, 2018, the 71st participant officially enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in …
On November 15, 2018, the 69th participant officially enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in …
From September 26-October 3, 2018, Annie Mithoefer, B.S.N., and Michael Mithoefer, M.D., led a weeklong in-person training in the Netherlands focused on MDMA-assisted psychotherapy in the treatment of …
In the coming year, MAPS plans to apply for a special U.S. Food and Drug Administration (FDA) program called Expanded Access (EA), which allows the use of an investigational medical product (one that has …
PRESS RELEASE: MDMA-Assisted Therapy Shows Promise for Reducing Social Anxiety in Autistic Adults, New Study Shows Results published in Psychopharmacology CONTACT: Brad Burge, Director of Strategic Communications, …
From July 16 – 19, 2018, MAPS-sponsored researchers Dr. Michael Mithoefer and Annie Mithoefer, BSN, Marcela Ot’alora, LPC, and Bruce Poulter, RN, together with MAPS Executive Director Rick …
